acetyl l-carnitine cancer treatment Metabolic Maintenance® Acetyl L-Carnitine
Description
Devasia J, Chinnam S, Khatana K, Shakya S, Joy F, Rudrapal M, et al
No serious AEs were reported at up to 28 days from the booster dose
Further clinical evaluation could provide evidence for sulforaphanes translational value in attenuating secondary brain injury after TBI
Nuno Empadinhas, Center for Neuroscience and Cell Biology, Portugal Copyright 2015 Young, Comas and de Carvalho
